Corcept Therapeutics Incorporated shares owned by Acadian Asset Management
Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Acadian Asset Management
from 13F filings
Historical chart of Acadian Asset Management investment in Corcept Therapeutics Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Corcept Therapeutics Incorporated held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Corcept Therapeutics Incorporated by Acadian Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.2M | 25k | 46.21 |
| 2024-06-30 | $912k | 28k | 32.46 |
| 2024-03-31 | $5.9M | 236k | 25.17 |
| 2023-09-30 | $8.7M | 318k | 27.21 |
| 2023-06-30 | $645k | 29k | 22.24 |
| 2023-03-31 | $204k | 9.4k | 21.63 |
| 2022-12-31 | $191k | 9.4k | 20.25 |
| 2022-09-30 | $790k | 31k | 25.64 |
| 2022-06-30 | $733k | 31k | 23.79 |
| 2022-03-31 | $716k | 32k | 22.48 |
| 2021-12-31 | $610k | 31k | 19.80 |
| 2021-09-30 | $530k | 27k | 19.66 |
| 2021-06-30 | $535k | 24k | 21.98 |
| 2021-03-31 | $454k | 19k | 23.77 |
| 2020-12-31 | $3.0M | 114k | 26.16 |
| 2020-09-30 | $2.6M | 148k | 17.40 |
| 2020-06-30 | $5.4M | 323k | 16.82 |
| 2020-03-31 | $4.2M | 351k | 11.90 |
| 2019-12-31 | $2.1M | 174k | 12.10 |
| 2019-09-30 | $2.9M | 208k | 14.14 |
| 2019-06-30 | $3.1M | 279k | 11.15 |
| 2019-03-31 | $4.8M | 412k | 11.74 |
| 2018-12-31 | $2.8M | 206k | 13.36 |
| 2018-09-30 | $20M | 1.4M | 14.02 |
| 2018-06-30 | $44M | 2.8M | 15.72 |
| 2018-03-31 | $55M | 3.3M | 16.45 |
| 2017-12-31 | $45M | 2.5M | 18.06 |
| 2017-09-30 | $44M | 2.3M | 19.30 |
| 2017-06-30 | $20M | 1.7M | 11.80 |
| 2017-03-31 | $12M | 1.1M | 10.96 |
| 2016-12-31 | $2.6M | 363k | 7.26 |
| 2016-09-30 | $1.2M | 187k | 6.50 |
| 2016-06-30 | $166k | 30k | 5.45 |
| 2016-03-31 | $290k | 62k | 4.70 |
| 2015-12-31 | $506k | 102k | 4.98 |
| 2015-09-30 | $796k | 212k | 3.76 |
| 2015-06-30 | $287k | 48k | 6.01 |
Top funds holding Corcept Therapeutics Incorporated
View all funds holding Corcept Therapeutics Incorporated